Apposite Capital News Today

Edinburgh-based Kelso Pharma has acquired Italys Velit Biopharma

Kelso Pharma has purchased two new dermatology products as it seeks to grow into a pan-European pharmaceutical business

Emblation invests £4m in Stirling base as demand for microwave technology

A health technology company has invested £4 million in new headquarters “to rival the best that Silicon Valley can offer”.

A SCOTTISH health tech firm has reached 100,000 completed treatments in the UK and Ireland, utilising its signature microwave device in the…

MORE than 30 people were made redundant this week after a South Lanarkshire construction company fell into liquidation.

A Scottish pharma business led by the former boss of Borders-based ProStrakan has been launched with a maiden acquisition.

Borders-based industry veteran Tom Stratford has launched a new pharmaceuticals business with the acquisition of Glasgows Stirling Anglian…

Catalan chef Miguel Angel Major is to launch a new look Rioja in Finnieston.

Gary Beale, chief executive, Emblation By Scott Wright AN Alloa-based medical device company that makes microwave-based solutions for skin conditions has secured an “eight-figure” investment to underpin its international growth ambitions. Emblation, which has developed a non-ablative treatment for common and plantar warts, has received the backing from Apposite Capital, a healthcare investor. It said the investment would “accelerate” its global growth plans as it targets doubling ...